Rapid communication Open Access
Like 0


A measles outbreak with 51 cases occurred in the canton of Vaud, Switzerland, between January and March 2024. The outbreak was triggered by an imported case, and 37 (72.5%) subsequent cases were previously vaccinated individuals. Epidemiological investigations showed that vaccinated measles cases were symptomatic and infectious. In a highly vaccinated population, it is important to raise awareness among healthcare professionals to suspect and test for measles virus when an outbreak is declared, irrespective of the vaccination status of the patients.


Article metrics loading...

Loading full text...

Full text loading...



  1. Federal Office of Public Health (FOPH). Bulletin OFSP: Une suisse sans rougeole. [Switzerland without measles]. Bern: FOPH; 1 Dec 2016. French. Available from: https://www.bag.admin.ch/bag/fr/home/strategie-und-politik/nationale-gesundheitsstrategien/nationale-strategie-masernelimination.html
  2. Federal Office of Public Health (FOPH). Suivi cantonal de la couverture vaccinale en Suisse. [Cantonal monitoring of vaccination coverage in Switzerland]. Bern: FOPH. [Accessed: 9 Feb 2024]. French. Available from: https://www.bag.admin.ch/bag/fr/home/gesund-leben/gesundheitsfoerderung-und-praevention/impfungen-prophylaxe/informationen-fachleute-gesundheitspersonal/durchimpfung.html
  3. Richard JL, Mäusezahl M, Basler S, Eckert N. Approaching measles elimination in Switzerland: changing epidemiology 2007-2018. Swiss Med Wkly. 2019;149:w20102.  https://doi.org/10.4414/smw.2019.20102  PMID: 31185128 
  4. World Health Organization Regional Office for Europe (WHO/Europe). Measles and rubella elimination country profile: Switzerland. Copenhagen: WHO/Europe; 2020. Available from: https://iris.who.int/handle/10665/337743
  5. Federal Office of Public Health (FOPH). Directives de lutte contre la rougeole et les flambées de rougeole. Directives et recommandations. [Guidelines for controlling measles and measles outbreaks. Guidelines and recommendations]. Bern: FOPH; 2019. French. Available from: https://www.bag.admin.ch/bag/fr/home/strategie-und-politik/nationale-gesundheitsstrategien/nationale-strategie-masernelimination.html
  6. Cherry JD, Zahn M. Clinical characteristics of measles in previously vaccinated and unvaccinated patients in California. Clin Infect Dis. 2018;67(9):1315-9.  https://doi.org/10.1093/cid/ciy286  PMID: 29878209 
  7. López-Perea N, Fernández-García A, Echevarría JE, de Ory F, Pérez-Olmeda M, Masa-Calles J. Measles in vaccinated people: epidemiology and challenges in surveillance and diagnosis in the post-elimination phase. Spain, 2014-2020. Viruses. 2021;13(10):1982.  https://doi.org/10.3390/v13101982  PMID: 34696412 
  8. Risco-Risco C, Masa-Calles J, López-Perea N, Echevarría JE, Rodríguez-Caravaca G. Epidemiology of measles in vaccinated people, Spain 2003-2014. Enferm Infecc Microbiol Clin. 2017;35(9):569-73.  https://doi.org/10.1016/j.eimc.2016.05.001  PMID: 27262819 
  9. Sundell N, Dotevall L, Sansone M, Andersson M, Lindh M, Wahlberg T, et al. Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections. Euro Surveill. 2019;24(17):1900114.  https://doi.org/10.2807/1560-7917.ES.2019.24.17.1900114  PMID: 31039835 
  10. Update of the nomenclature for describing the genetic characteristics of wild-type measles viruses: new genotypes and reference strains. Wkly Epidemiol Rec. 2003;78(27):229-32. PMID: 12866261 
  11. Genetic diversity of wild-type measles viruses and the global measles nucleotide surveillance database (MeaNS). Wkly Epidemiol Rec. 2015;90(30):373-80. PMID: 26211016 
  12. Benson DA, Cavanaugh M, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J, et al. GenBank. Nucleic Acids Res. 2013;41(Database issue):D36-42. PMID: 23193287 
  13. Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63(6):1055-68. PMID: 3879673 
  14. Kurata T, Yamamoto SP, Nishimura H, Yumisashi T, Motomura K, Kinoshita M. A measles outbreak in Kansai International Airport, Japan, 2016: Analysis of the quantitative difference and infectivity of measles virus between patients who are immunologically naive versus those with secondary vaccine failure. J Med Virol. 2021;93(6):3446-54.  https://doi.org/10.1002/jmv.26733  PMID: 33325052 
  15. Komabayashi K, Seto J, Tanaka S, Suzuki Y, Ikeda T, Onuki N, et al. The largest measles outbreak, including 38 modified measles and 22 typical measles cases in its elimination era in Yamagata, Japan, 2017. Jpn J Infect Dis. 2018;71(6):413-8.  https://doi.org/10.7883/yoken.JJID.2018.083  PMID: 29962488 
  16. Bianchi S, Gori M, Fappani C, Ciceri G, Canuti M, Colzani D, et al. Characterization of vaccine breakthrough cases during measles outbreaks in Milan and surrounding areas, Italy, 2017-2021. Viruses. 2022;14(5):1068.  https://doi.org/10.3390/v14051068  PMID: 35632809 
  17. Hahné SJ, Nic Lochlainn LM, van Burgel ND, Kerkhof J, Sane J, Yap KB, et al. Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014. J Infect Dis. 2016;214(12):1980-6.  https://doi.org/10.1093/infdis/jiw480  PMID: 27923955 
  18. Rota JS, Hickman CJ, Sowers SB, Rota PA, Mercader S, Bellini WJ. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis. 2011;204(Suppl 1):S559-63.  https://doi.org/10.1093/infdis/jir098  PMID: 21666213 
  19. Rosen JB, Rota JS, Hickman CJ, Sowers SB, Mercader S, Rota PA, et al. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011. Clin Infect Dis. 2014;58(9):1205-10.  https://doi.org/10.1093/cid/ciu105  PMID: 24585562 
  20. Iwamoto M, Hickman CJ, Colley H, Arciuolo RJ, Mahle CE, Deocharan B, et al. Measles infection in persons with secondary vaccine failure, New York City, 2018-19. Vaccine. 2021;39(38):5346-50.  https://doi.org/10.1016/j.vaccine.2021.07.078  PMID: 34393016 
  21. Zhang Z, Chen M, Ma R, Pan J, Suo L, Lu L. Outbreak of measles among persons with secondary vaccine failure, China, 2018. Hum Vaccin Immunother. 2020;16(2):358-62.  https://doi.org/10.1080/21645515.2019.1653742  PMID: 31487215 
  22. Orenstein W, Offit P, Edwards K, Plotkin S. Plotkin's Vaccines. 8th Edition. Amsterdam: Elsevier; 2022. p. 1808
  23. World Health Organization. Measles vaccines: WHO position paper, April 2017 - recommendations. Vaccine. 2019;37(2):219-22.  https://doi.org/10.1016/j.vaccine.2017.07.066  PMID: 28760612 
  24. Ministère du Travail, de la Santé et des Solidarités (Santé). Recommandations sanitaires dans le cadre de l’épidémie de rougeole touchant l’Ardèche et la Drôme depuis septembre 2023. [Health recommendations on the measles outbreak affecting Ardèche et Drôme since September 2023]. Paris: Santé; 16 Nov 2023. French. Available from: https://sante.gouv.fr/IMG/pdf/dgs-urgent_n02023_21_rougeole_ara.pdf
  25. Nic Lochlainn LM, de Gier B, van der Maas N, van Binnendijk R, Strebel PM, Goodman T, et al. Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19(11):1246-54.  https://doi.org/10.1016/S1473-3099(19)30396-2  PMID: 31548081 

Data & Media loading...

Supplementary data

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error